O	0	7	Protein	Protein	NN	B-NP
O	8	18	expression	expression	NN	I-NP
O	19	26	profile	profile	NN	I-NP
O	27	29	of	of	IN	B-PP
B-Cancer	30	37	primary	primary	JJ	B-NP
I-Cancer	38	43	human	human	JJ	I-NP
I-Cancer	44	52	squamous	squamous	JJ	I-NP
I-Cancer	53	57	cell	cell	NN	I-NP
I-Cancer	58	62	lung	lung	NN	I-NP
I-Cancer	63	73	carcinomas	carcinoma	NNS	I-NP
O	74	84	indicative	indicative	JJ	B-ADJP
O	85	87	of	of	IN	B-PP
O	88	91	the	the	DT	B-NP
O	92	101	incidence	incidence	NN	I-NP
O	102	104	of	of	IN	B-PP
B-Cancer	105	115	metastases	metastasis	NNS	B-NP
O	115	116	.	.	.	O

O	118	121	The	The	DT	B-NP
O	122	129	purpose	purpose	NN	I-NP
O	130	132	of	of	IN	B-PP
O	133	137	this	this	DT	B-NP
O	138	151	investigation	investigation	NN	I-NP
O	152	155	was	be	VBD	B-VP
O	156	158	to	to	TO	B-VP
O	159	167	evaluate	evaluate	VB	I-VP
O	168	175	firstly	firstly	RB	B-ADVP
O	176	183	whether	whether	IN	B-SBAR
O	184	193	different	different	JJ	B-NP
O	194	201	protein	protein	NN	I-NP
O	202	212	expression	expression	NN	I-NP
O	213	221	patterns	pattern	NNS	I-NP
O	222	227	exist	exist	VBP	B-VP
O	228	230	in	in	IN	B-PP
B-Cancer	231	238	primary	primary	JJ	B-NP
I-Cancer	239	247	squamous	squamous	JJ	I-NP
I-Cancer	248	252	cell	cell	NN	I-NP
I-Cancer	253	257	lung	lung	NN	I-NP
I-Cancer	258	268	carcinomas	carcinoma	NNS	I-NP
O	269	271	of	of	IN	B-PP
O	272	280	patients	patient	NNS	B-NP
O	281	285	with	with	IN	B-PP
O	286	289	and	and	CC	I-PP
O	290	297	without	without	IN	I-PP
B-Multi-tissue_structure	298	303	lymph	lymph	NN	B-NP
I-Multi-tissue_structure	304	308	node	node	NN	I-NP
O	309	320	involvement	involvement	NN	I-NP
O	321	324	and	and	CC	O
O	325	333	secondly	secondly	RB	B-ADVP
O	333	334	,	,	,	O
O	335	342	whether	whether	IN	B-SBAR
O	343	345	or	or	CC	O
O	346	349	not	not	RB	O
O	350	359	different	different	JJ	B-NP
O	360	368	patterns	pattern	NNS	I-NP
O	369	374	exist	exist	VBP	B-VP
O	375	377	in	in	IN	B-PP
B-Cancer	378	385	tumours	tumour	NNS	B-NP
O	386	390	with	with	IN	B-PP
O	391	399	positive	positive	JJ	B-NP
B-Multi-tissue_structure	400	405	lymph	lymph	NN	I-NP
I-Multi-tissue_structure	406	411	nodes	node	NNS	I-NP
O	411	412	.	.	.	O

O	413	416	For	For	IN	B-PP
O	417	421	this	this	DT	B-NP
O	422	428	reason	reason	NN	I-NP
O	428	429	,	,	,	O
O	430	438	formalin	formalin	NN	B-NP
O	438	439	-	-	HYPH	O
O	439	444	fixed	fix	VBN	B-VP
O	444	445	,	,	,	O
O	446	454	paraffin	paraffin	NN	B-NP
O	454	455	-	-	HYPH	B-NP
O	455	463	embedded	embed	VBN	I-NP
B-Tissue	464	473	specimens	specimen	NNS	I-NP
O	474	478	from	from	IN	B-PP
O	479	482	130	130	CD	B-NP
O	483	491	patients	patient	NNS	I-NP
O	492	496	with	with	IN	B-PP
B-Cancer	497	505	squamous	squamous	JJ	B-NP
I-Cancer	506	510	cell	cell	NN	I-NP
I-Cancer	511	515	lung	lung	NN	I-NP
I-Cancer	516	526	carcinomas	carcinoma	NNS	I-NP
O	527	531	were	be	VBD	B-VP
O	532	540	analyzed	analyze	VBN	I-VP
O	541	543	by	by	IN	B-PP
O	544	564	immunohistochemistry	immunohistochemistry	NN	B-NP
O	564	565	.	.	.	O

O	566	568	In	In	IN	B-PP
O	569	570	a	a	DT	B-NP
O	571	576	first	first	JJ	I-NP
O	577	581	step	step	NN	I-NP
O	581	582	,	,	,	O
O	583	591	proteins	protein	NNS	B-NP
O	592	596	were	be	VBD	B-VP
O	597	605	selected	select	VBN	I-VP
O	606	611	which	which	WDT	B-NP
O	612	618	showed	show	VBD	B-VP
O	619	620	a	a	DT	B-NP
O	621	633	relationship	relationship	NN	I-NP
O	634	636	to	to	TO	B-PP
B-Multi-tissue_structure	637	642	lymph	lymph	NN	B-NP
I-Multi-tissue_structure	643	647	node	node	NN	I-NP
O	648	659	involvement	involvement	NN	I-NP
O	659	660	.	.	.	O

O	661	664	The	The	DT	B-NP
O	665	675	expression	expression	NN	I-NP
O	676	678	of	of	IN	B-PP
O	679	682	JUN	JUN	NN	B-NP
O	682	683	,	,	,	O
O	684	689	ERBB2	ERBB2	NN	B-NP
O	689	690	,	,	,	O
O	691	694	MYC	MYC	NN	B-NP
O	694	695	,	,	,	O
O	696	702	cyclin	cyclin	NN	B-NP
O	703	704	D	D	NN	I-NP
O	704	705	,	,	,	O
O	706	710	PCNA	PCNA	NN	B-NP
O	710	711	,	,	,	O
O	712	716	bFGF	bFGF	NN	B-NP
O	716	717	,	,	,	O
O	718	722	VEGF	VEGF	NN	B-NP
O	723	726	and	and	CC	I-NP
O	727	732	Hsp70	Hsp70	NN	I-NP
O	733	741	proteins	protein	NNS	I-NP
O	742	750	revealed	reveal	VBD	B-VP
O	751	752	a	a	DT	B-NP
O	753	761	positive	positive	JJ	I-NP
O	762	773	correlation	correlation	NN	I-NP
O	774	776	to	to	TO	B-PP
B-Multi-tissue_structure	777	782	lymph	lymph	NN	B-NP
I-Multi-tissue_structure	783	787	node	node	NN	I-NP
O	788	799	involvement	involvement	NN	I-NP
O	799	800	.	.	.	O

O	801	803	In	In	IN	B-PP
O	804	812	contrast	contrast	NN	B-NP
O	812	813	,	,	,	O
O	814	821	caspase	caspase	NN	B-NP
O	821	822	-	-	HYPH	B-NP
O	822	823	3	3	CD	I-NP
O	823	824	,	,	,	O
O	825	828	Fas	Fas	NN	B-NP
O	829	835	ligand	ligand	NN	I-NP
O	835	836	,	,	,	O
O	837	840	Fas	Fas	NN	B-NP
O	840	841	/	/	SYM	B-NP
O	841	845	CD95	CD95	NN	I-NP
O	845	846	,	,	,	O
O	847	850	and	and	CC	O
O	851	854	PAI	PAI	NN	B-NP
O	855	861	showed	show	VBD	B-VP
O	862	864	an	an	DT	B-NP
O	865	872	inverse	inverse	JJ	I-NP
O	873	884	correlation	correlation	NN	I-NP
O	885	887	to	to	TO	B-PP
B-Multi-tissue_structure	888	893	lymph	lymph	NN	B-NP
I-Multi-tissue_structure	894	898	node	node	NN	I-NP
O	899	910	involvement	involvement	NN	I-NP
O	910	911	.	.	.	O

O	912	914	In	In	IN	B-PP
O	915	916	a	a	DT	B-NP
O	917	923	second	second	JJ	I-NP
O	924	928	step	step	NN	I-NP
O	928	929	,	,	,	O
O	930	935	these	these	DT	B-NP
O	936	946	parameters	parameter	NNS	I-NP
O	947	951	were	be	VBD	B-VP
O	952	959	further	further	RB	I-VP
O	960	968	analyzed	analyze	VBN	I-VP
O	969	971	by	by	IN	B-PP
O	972	984	hierarchical	hierarchical	JJ	B-NP
O	985	992	cluster	cluster	NN	I-NP
O	993	1001	analyses	analysis	NNS	I-NP
O	1001	1002	.	.	.	O

O	1003	1006	The	The	DT	B-NP
O	1007	1016	resulting	result	VBG	I-NP
O	1017	1025	clusters	cluster	NNS	I-NP
O	1026	1030	were	be	VBD	B-VP
O	1031	1041	correlated	correlate	VBN	I-VP
O	1042	1044	to	to	TO	B-PP
O	1045	1053	patients	patient	NNS	B-NP
O	1054	1058	with	with	IN	B-PP
O	1059	1061	or	or	CC	B-PP
O	1062	1069	without	without	IN	B-PP
B-Multi-tissue_structure	1070	1075	lymph	lymph	NN	B-NP
I-Multi-tissue_structure	1076	1080	node	node	NN	I-NP
O	1081	1092	involvement	involvement	NN	I-NP
O	1092	1093	.	.	.	O

O	1094	1097	The	The	DT	B-NP
O	1098	1102	data	datum	NNS	I-NP
O	1103	1107	show	show	VBP	B-VP
O	1108	1112	that	that	IN	B-SBAR
O	1113	1122	different	different	JJ	B-NP
O	1123	1130	protein	protein	NN	I-NP
O	1131	1141	expression	expression	NN	I-NP
O	1142	1150	patterns	pattern	NNS	I-NP
O	1151	1156	exist	exist	VBP	B-VP
O	1157	1164	between	between	IN	B-PP
B-Cancer	1165	1172	primary	primary	JJ	B-NP
I-Cancer	1173	1181	squamous	squamous	JJ	I-NP
I-Cancer	1182	1186	cell	cell	NN	I-NP
I-Cancer	1187	1191	lung	lung	NN	I-NP
I-Cancer	1192	1202	carcinomas	carcinoma	NNS	I-NP
O	1203	1207	with	with	IN	B-PP
O	1208	1211	and	and	CC	I-PP
O	1212	1219	without	without	IN	I-PP
B-Multi-tissue_structure	1220	1225	lymph	lymph	NN	B-NP
I-Multi-tissue_structure	1226	1230	node	node	NN	I-NP
O	1231	1242	involvement	involvement	NN	I-NP
O	1243	1246	and	and	CC	B-PP
O	1247	1253	within	within	IN	B-PP
B-Cancer	1254	1264	carcinomas	carcinoma	NNS	B-NP
O	1265	1269	with	with	IN	B-PP
B-Multi-tissue_structure	1270	1275	lymph	lymph	NN	B-NP
I-Multi-tissue_structure	1276	1280	node	node	NN	I-NP
O	1281	1292	involvement	involvement	NN	I-NP
O	1292	1293	.	.	.	O

O	1294	1297	The	The	DT	B-NP
O	1298	1302	data	datum	NNS	I-NP
O	1303	1310	suggest	suggest	VBP	B-VP
O	1311	1315	that	that	IN	B-SBAR
O	1316	1323	various	various	JJ	B-NP
O	1324	1334	metastasis	metastasis	NN	I-NP
O	1335	1343	profiles	profile	NNS	I-NP
O	1344	1349	exist	exist	VBP	B-VP
O	1349	1350	.	.	.	O

